AnaptysBio Inc buy Piper Sandler
Start price
16.02.24
/
50%
€22.00
Target price
16.02.25
€74.42
Performance (%)
-2.73%
Price
30.04.24
€22.80
Summary
This prediction is currently active. With a performance of -2.73%, the BUY prediction for AnaptysBio Inc by Piper_Sandler is down slightly. This prediction currently runs until 16.02.25. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| AnaptysBio Inc | 27.374% | 27.374% |
| iShares Core DAX® | -0.992% | -3.231% |
| iShares Nasdaq 100 | -0.225% | -3.339% |
| iShares Nikkei 225® | -0.736% | -7.859% |
| iShares S&P 500 | -0.509% | -2.979% |
Comments by Piper_Sandler for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $80.00 price target on the stock.
Ratings data for ANAB provided by MarketBeat